Entering text into the input field will update the search result below

Renalytix: Laying The Foundations For Growth

Jan. 05, 2022 12:15 PM ETRenalytix Plc (RNLX)11 Comments
Retirement Pot profile picture
Retirement Pot


  • Renalytix has grown its revenue but it's still miniscule. That should change this year.
  • A stronger sales function combined with mounting clinical data could help sign on new healthcare users and drive scale.
  • I remain bullish on the prospects for the company and see price upside this year.

Young African-American man complained of kidney pain.

Ika84/E+ via Getty Images

Kidney diagnostics specialist Renalytix (NASDAQ:RNLX) had an underwhelming 2021 in terms of share price performance. But the underlying potential for the business has moved forward in the past year.

The Company Has been Moving towards Commercialisation

This article was written by

Retirement Pot profile picture
I am a private investor based in the United Kingdom and most interested in equities in the U.K., U.S., Canada and Norway.

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, but may initiate a beneficial Long position through a purchase of the stock, or the purchase of call options or similar derivatives in RNLX over the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.